Xu, Yang <br/><br/>
Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations.  [electronic resource] 

 -  American journal of hematology  Nov 2015 
 - 992-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1096-8652 
<br/><br/><label>Standard No.: </label>10.1002/ajh.24135  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>CCAAT-Enhancer-Binding Proteins--genetics<br/>Cytogenetic Analysis<br/>DNA (Cytosine-5-)-Methyltransferases--genetics<br/>DNA Methyltransferase 3A<br/>Female<br/>Gene Expression<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Leukemia, Myeloid, Acute--genetics<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Mutation<br/>Nuclear Proteins--genetics<br/>Nucleophosmin<br/>Prognosis<br/>Remission Induction<br/>Retrospective Studies<br/>Survival Analysis<br/>Transplantation, Homologous<br/>fms-Like Tyrosine Kinase 3--genetics